Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Pharmacology, Biochemistry, and Behavior|April 6, 2020
In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018Thomas F Gamage, Daniel G Barrus, Richard C Kevin, et al.
Drug Testing and Analysis|March 7, 2019
The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogsSamuel D Banister, Richard C Kevin, Lewis Martin, et al.
ACS Chemical Neuroscience|July 3, 2015
Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICASamuel D Banister, Michael Moir, Jordyn Stuart, et al.
Drug Testing and Analysis|August 29, 2018
Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACASamuel D Banister, Axel Adams, Richard C Kevin, et al.
ACS Chemical Neuroscience|April 11, 2022
Defining Steric Requirements at CB1 and CB2 Cannabinoid Receptors Using Synthetic Cannabinoid Receptor Agonists 5F-AB-PINACA, 5F-ADB-PINACA, PX-1, PX-2, NNL-1, and Their AnaloguesJack Markham, Eric Sparkes, Rochelle Boyd, et al.
RSC Medicinal Chemistry|March 21, 2022
Structure-activity relationships of valine, tert-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICAEric Sparkes, Elizabeth A Cairns, Richard C Kevin, et al.
ACS Chemical Neuroscience|April 20, 2022
Putative Synthetic Cannabinoids MEPIRAPIM, 5F-BEPIRAPIM (NNL-2), and Their Analogues Are T-Type Calcium Channel (CaV3) InhibitorsRichard C Kevin, Somayeh Mirlohi, Jamie J Manning, et al.
ACS Chemical Neuroscience|October 22, 2021
NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity?Adam Ametovski, Elizabeth A Cairns, Katharina Elisabeth Grafinger, et al.
Frontiers in Psychiatry|October 17, 2022
Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogsEric Sparkes, Rochelle Boyd, Shuli Chen, et al.
Pharmacological Reviews|June 10, 2026
International Union of Basic and Clinical Pharmacology. CXXII. Applying an objective evaluation to the status of class A orphan G protein-coupled receptorsStephen P H Alexander, Kirstie A Bennett, Andrew J Brown, et al.
Pageof 13